• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神健康服务提供者在通过远程医疗开处方时面临的挑战与解决方案:半结构化访谈的内容分析

Mental Health Providers' Challenges and Solutions in Prescribing Over Telemedicine: Content Analysis of Semistructured Interviews.

作者信息

Ivanova Julia, Cummins Mollie R, Soni Hiral, Ong Triton, Bunnell Brian E, López Esteban, Welch Brandon M

机构信息

Doxy.me Research, Doxy.me Inc, Charleston, SC, United States.

Department of Biomedical Informatics, College of Nursing and Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.

出版信息

JMIR Hum Factors. 2025 Mar 20;12:e65419. doi: 10.2196/65419.

DOI:10.2196/65419
PMID:40112291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11969126/
Abstract

BACKGROUND

In response to the COVID-19 pandemic, the United States extended regulatory flexibilities to make telemedicine more accessible to providers and patients. Some of these flexibilities allowed providers to intake patients over telemedicine and prescribe certain scheduled medications without an in-person visit.

OBJECTIVE

We aim to understand providers' parameters for their comfort in prescribing over telemedicine and report on solutions providers have adopted in response to potential barriers and challenges in prescribing via telemedicine.

METHODS

As part of a larger mixed methods study between February and April 2024, we conducted 16 semistructured interviews with mental health providers who prescribe via telemedicine within the United States. We used the results of a web-based, cross-sectional survey to develop a codebook and support recruitment. We analyzed a subsection of the 16 interviews using content analysis to capture comfort, barriers, and workarounds in telemedicine prescribing. We reported codes by frequency and by provider.

RESULTS

Participants were typically male (11/16, 69%), provided care mostly or completely over telemedicine (11/16, 69%), and were psychiatrists (8/16, 50%) or other physician (3/16, 19%). Providers' primary states (10/16, 62%) of practice included Oregon, Texas, New York, and California. The content analysis yielded a total of 234 codes, with three main codes-comfort (98/234, 41.9%), barriers or challenges (85/234, 36.3%), and workarounds or solutions (27/234, 11.5%)-and two subcodes-uncomfortable prescribing (30/98, 31%) and comfortable prescribing (68/98, 69%) over telemedicine. Participants reported being comfortable prescribing over telemedicine as long as they could meet their main parameters of working within their expertise, having access to needed patient health information, and being compliant with rules and regulations. Participants reported frustrations with e-prescription workflows and miscommunications with pharmacies. Solutions to ease frustrations and alleviate discomforts in prescribing over telemedicine included developing workflows to help patients complete laboratory tests and physical examinations and directly communicating with pharmacies.

CONCLUSIONS

By applying content analysis to the semistructured provider interviews, we found that physicians are comfortable prescribing via telemedicine when they feel they are practicing within their personal parameters for safety. While many providers experience frustrations such as miscommunication with pharmacies, these barriers appear to not prevent them from telemedicine prescribing. With expected changes in 2024 and 2025 to the US laws and regulations for telemedicine prescribing, we may see changes in provider comfort in prescribing.

摘要

背景

为应对新冠疫情,美国放宽了监管灵活性,以使远程医疗对医疗服务提供者和患者而言更易获得。其中一些灵活性措施允许医疗服务提供者通过远程医疗接诊患者并开具某些处方药,而无需进行面对面就诊。

目的

我们旨在了解医疗服务提供者对通过远程医疗开处方感到安心的参数,并报告医疗服务提供者针对远程医疗开处方中潜在障碍和挑战所采取的解决方案。

方法

作为2024年2月至4月一项规模更大的混合方法研究的一部分,我们对美国境内通过远程医疗开处方的心理健康服务提供者进行了16次半结构化访谈。我们利用一项基于网络的横断面调查结果来制定编码手册并支持招募工作。我们运用内容分析法对16次访谈中的一个子部分进行分析,以获取远程医疗开处方中的安心因素、障碍和应对方法。我们按出现频率和提供者报告编码情况。

结果

参与者大多为男性(11/16,69%),主要或完全通过远程医疗提供护理(11/16,69%),并且是精神科医生(8/16,50%)或其他医生(3/16,19%)。医疗服务提供者执业的主要州(10/16,62%)包括俄勒冈州、得克萨斯州、纽约州和加利福尼亚州。内容分析共产生了234个编码,有三个主要编码——安心因素(98/234,41.9%)、障碍或挑战(85/234,36.3%)以及应对方法或解决方案(27/234,11.5%)——还有两个子编码——远程医疗开处方时不安心(30/98,31%)和安心(68/98,69%)。参与者报告称,只要能满足其在专业范围内工作、获取所需患者健康信息以及遵守规章制度等主要参数,他们就对通过远程医疗开处方感到安心。参与者报告了对电子处方工作流程的不满以及与药房的沟通不畅。缓解远程医疗开处方中的不满和不适的解决方案包括制定工作流程以帮助患者完成实验室检查和体格检查,以及与药房直接沟通。

结论

通过对医疗服务提供者的半结构化访谈应用内容分析法,我们发现医生在觉得自己是在个人安全参数范围内执业时,对通过远程医疗开处方感到安心。虽然许多医疗服务提供者会遇到如与药房沟通不畅等挫折,但这些障碍似乎并未阻止他们进行远程医疗开处方。随着2024年和2025年美国远程医疗开处方法律法规的预期变化,我们可能会看到医疗服务提供者开处方时的安心程度发生变化。

相似文献

1
Mental Health Providers' Challenges and Solutions in Prescribing Over Telemedicine: Content Analysis of Semistructured Interviews.精神健康服务提供者在通过远程医疗开处方时面临的挑战与解决方案:半结构化访谈的内容分析
JMIR Hum Factors. 2025 Mar 20;12:e65419. doi: 10.2196/65419.
2
Telemedicine Prescribing by US Mental Health Care Providers: National Cross-Sectional Survey.美国精神卫生保健提供者的远程医疗处方:全国横断面调查
JMIR Form Res. 2025 Mar 11;9:e63251. doi: 10.2196/63251.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
5
Antibiotic Prescribing by Digital Health Care Providers as Compared to Traditional Primary Health Care Providers: Cohort Study Using Register Data.数字医疗保健提供者与传统初级保健提供者开具抗生素处方的比较:使用登记数据的队列研究。
J Med Internet Res. 2024 Jun 26;26:e55228. doi: 10.2196/55228.
6
Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.美国临床医生在 COVID-19 大流行期间利用扩大的授权开具丁丙诺啡治疗阿片类药物使用障碍处方的特征和相关性。
Drug Alcohol Depend. 2021 Aug 1;225:108783. doi: 10.1016/j.drugalcdep.2021.108783. Epub 2021 May 23.
7
Buprenorphine prescribing practice trends and attitudes among New York providers.纽约医疗服务提供者丁丙诺啡的处方开具实践趋势及态度
J Subst Abuse Treat. 2017 Mar;74:1-6. doi: 10.1016/j.jsat.2016.10.005. Epub 2016 Oct 29.
8
Telehealth Uptake into Prenatal Care and Provider Attitudes during the COVID-19 Pandemic in New York City: A Quantitative and Qualitative Analysis.纽约市新冠疫情期间远程医疗在产前护理中的应用及提供者态度:一项定量与定性分析
Am J Perinatol. 2020 Aug;37(10):1005-1014. doi: 10.1055/s-0040-1712939. Epub 2020 Jun 9.
9
'Here to stay': changes to prescribing medication in general practice during the COVID-19 pandemic in New Zealand.“留在这里”:新西兰 COVID-19 大流行期间全科医生开处方药的变化。
J Prim Health Care. 2021 Sep;13(3):222-230. doi: 10.1071/HC21035.
10
Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.阿片类药物安全措施的存在、阿片类药物和纳洛酮的处方模式,以及开具纳洛酮的感知障碍:基于实践类型、范围和地点的横断面调查结果。
J Opioid Manag. 2021 Jan-Feb;17(1):19-38. doi: 10.5055/jom.2021.0611.

引用本文的文献

1
Perceptions and Attitudes Toward Telepsychiatry Among Patients and Psychiatrists: A Mixed-Methods Study in Saudi Arabia.沙特阿拉伯患者和精神科医生对远程精神病学的认知与态度:一项混合方法研究
Cureus. 2025 Jul 19;17(7):e88309. doi: 10.7759/cureus.88309. eCollection 2025 Jul.
2
Nursing and Continuing Care Management Work Plan for People Living With COVID-19: Case Study of the Nakhon Pathom Province.新冠肺炎患者护理与持续照护管理工作计划:佛统府案例研究
JMIR Nurs. 2025 May 29;8:e65310. doi: 10.2196/65310.

本文引用的文献

1
Telemedicine Prescribing by US Mental Health Care Providers: National Cross-Sectional Survey.美国精神卫生保健提供者的远程医疗处方:全国横断面调查
JMIR Form Res. 2025 Mar 11;9:e63251. doi: 10.2196/63251.
2
Telemedicine for Initiation of Alcohol Use Disorder Medications.用于启动酒精使用障碍药物治疗的远程医疗
JAMA Netw Open. 2024 Sep 3;7(9):e2431594. doi: 10.1001/jamanetworkopen.2024.31594.
3
Will the United States pass on telemedicine progress?美国会错失远程医疗的发展成果吗?
JAMIA Open. 2024 Feb 26;7(1):ooae016. doi: 10.1093/jamiaopen/ooae016. eCollection 2024 Apr.
4
Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States.丁丙诺啡治疗的大流行期间远程医疗灵活性:美国扩大阿片类药物使用障碍护理的证据综合及政策影响
Health Aff Sch. 2023 Jun 20;1(1):qxad013. doi: 10.1093/haschl/qxad013. eCollection 2023 Jul.
5
Telehealth in opioid use disorder treatment: policy considerations for expanding access to care.远程医疗在阿片类药物使用障碍治疗中的应用:扩大医疗服务可及性的政策考虑。
J Osteopath Med. 2023 Nov 20;124(4):179-181. doi: 10.1515/jom-2023-0215. eCollection 2024 Apr 1.
6
Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees.远程医疗在医疗补助受种者阿片类药物使用障碍治疗中的丁丙诺啡起始和维持。
JAMA Netw Open. 2023 Oct 2;6(10):e2336914. doi: 10.1001/jamanetworkopen.2023.36914.
7
Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.新冠疫情期间美国远程医疗的使用情况及其对阿片类药物使用障碍治疗质量的影响。
JAMA Netw Open. 2023 Jan 3;6(1):e2252381. doi: 10.1001/jamanetworkopen.2022.52381.
8
Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States.美国 COVID-19 大流行期间物质使用障碍治疗过程中的远程医疗。
Drug Alcohol Depend. 2023 Jan 1;242:109711. doi: 10.1016/j.drugalcdep.2022.109711. Epub 2022 Nov 23.
9
Physician, Nurse, and Advanced Practice Provider Perspectives on the Rapid Transition to Inpatient and Outpatient Telemedicine.医生、护士和高级执业提供者对快速过渡到住院和门诊远程医疗的看法。
Telemed Rep. 2022 Jan 10;3(1):7-14. doi: 10.1089/tmr.2021.0034. eCollection 2022.
10
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.理解 COVID-19 大流行期间远程医疗提供丁丙诺啡所带来的机遇和挑战。
J Subst Abuse Treat. 2022 Aug;139:108777. doi: 10.1016/j.jsat.2022.108777. Epub 2022 Mar 25.